Miyashita Takenori, Inamoto Ryuhei, Fukuda Shinjiro, Hoshikawa Hiroshi, Hitomi Hirofumi, Kiyomoto Hideyasu, Nishiyama Akira, Mori Nozomu
Department of Otolaryngology, Kagawa University, Kagawa, Japan.
Department of Otolaryngology, Kagawa University, Kagawa, Japan.
Auris Nasus Larynx. 2017 Feb;44(1):52-57. doi: 10.1016/j.anl.2016.03.001. Epub 2016 Mar 28.
A low-salt diet has been the main treatment modality for Ménière's disease (MD) since the 1930s, although the mechanisms behind this therapy have not yet been elucidated. Salt reduction is associated with a physiological increase in plasma aldosterone concentration. Several experimental reports have suggested that aldosterone may increase endolymph absorption in the inner ear, particularly in the endolymphatic sac. Therefore, aldosterone elevations due to a low-salt diet may increase endolymph absorption in the endolymphatic sac. In this study, urinary sodium excretion, plasma aldosterone, and other hormones were measured during low-salt diet therapy in patients with MD.
We included 13 patients with unilateral definite MD diagnosed at the Kagawa University Hospital. A national registered dietitian provided nutritional guidance initially for 14 enrolled patients with MD and prescribed them a low-salt diet (2g Na/day). Twenty-four hour urine was sampled at baseline, at 2, 4, 6, and 8 weeks, and at 6, 12, 18, and 24 months after initiating the low-salt diet. Urine osmotic pressure, and Na, K, and Cl levels were measured, and 24-h urinary Na, K, and Cl excretion was estimated. Aldosterone, cortisol, hormones (including anti-diuretic hormone), Na, K, and Cl in the blood were measured, alongside plasma osmotic pressure. A total of 13 patients followed the low salt diet therapy for more than 2 years, while one patient dropped out.
Group 1 (n=7) included patients with a mean urinary sodium excretion amount lower than 3g/day and Group 2 (n=6) included those with more than 3g/day. Vertiginous states of all Group 1 patients comprised complete control (Class A, 100%), while Group 2 patients included Class A (four patients, 66%), Class C (one patient, 17%), and Class D (one patients, 17%). Plasma aldosterone concentrations significantly increased during the 2-year low-salt diet; concentrations in Group 1 tended to be higher than that in Group 2. Hearing improvements after 2 years in Group 1 were significantly better than that in Group 2. The plasma concentration of the hormones except aldosterone was not significantly changed during 2-year low-salt diet.
A low-salt diet was an effective treatment for patients with Ménière's disease. This treatment will have a greater effect, when sodium intake is reduced to less than 3g/day. A low-salt diet may induce an increase in the plasma aldosterone concentration that can activate ion transport and absorbing endolymph in the endolymphatic sac.
自20世纪30年代以来,低盐饮食一直是梅尼埃病(MD)的主要治疗方式,尽管该疗法背后的机制尚未阐明。盐摄入量减少与血浆醛固酮浓度的生理性升高有关。多项实验报告表明,醛固酮可能会增加内耳尤其是内淋巴囊的内淋巴吸收。因此,低盐饮食导致的醛固酮升高可能会增加内淋巴囊的内淋巴吸收。在本研究中,对MD患者低盐饮食治疗期间的尿钠排泄、血浆醛固酮及其他激素进行了测量。
我们纳入了13例在香川大学医院确诊为单侧明确MD的患者。一名国家注册营养师最初为14名入组的MD患者提供营养指导,并为他们规定了低盐饮食(2克钠/天)。在开始低盐饮食的基线、第2、4、6和8周以及第6、12、18和24个月采集24小时尿液样本。测量尿渗透压以及钠、钾和氯水平,并估算24小时尿钠、钾和氯排泄量。测量血液中的醛固酮、皮质醇、激素(包括抗利尿激素)、钠、钾和氯,以及血浆渗透压。共有13例患者接受低盐饮食治疗超过2年,1例患者退出。
第1组(n = 7)包括平均尿钠排泄量低于3克/天的患者,第2组(n = 6)包括尿钠排泄量超过3克/天的患者。第1组所有患者的眩晕状态均为完全控制(A级,100%),而第2组患者包括A级(4例患者,66%)、C级(1例患者,17%)和D级(1例患者,17%)。在为期2年的低盐饮食期间,血浆醛固酮浓度显著升高;第1组的浓度往往高于第2组。第1组2年后的听力改善明显优于第2组。在为期2年的低盐饮食期间,除醛固酮外的其他激素的血浆浓度没有显著变化。
低盐饮食对梅尼埃病患者是一种有效的治疗方法。当钠摄入量减少到每天低于3克时,这种治疗效果会更好。低盐饮食可能会导致血浆醛固酮浓度升高,从而激活内淋巴囊中的离子转运并吸收内淋巴。